Rigaku Announces Narcotics Interdiction Partnership Program to Help Reduce Deaths by Overdose

Rigaku will partner with overdose prevention centers to fight the opioid epidemic

Wilmington, MA (May 10, 2022) – In conjunction with the U.S. Drug Enforcement Agency (DEA)’s declaration of National Fentanyl Awareness Day, Rigaku Analytical Devices, a U.S.-based pioneer of handheld 1064 nm-Raman based spectrometers, is pleased to announce its new Human Infrastructure Health & Awareness (HIHA) Technology Narcotics Identification Partnership Program.  This HIHA Program was developed to assist government health and social administration departments, and law enforcement agencies, in their efforts to reduce the increasing rates of unintentional drug overdoses and fatalities, related to opioid addiction and fentanyl poisoning.

Image credit: Rigaku

As many communities consider the decriminalization of illicit drugs, and thus an increase in drug use, harm reduction programs that include overdose prevention centers (OPCs) are being funded as a means to help prevent fatal overdoses.  OPCs provide a place for users to consume drugs using sterile equipment with access to health care professionals who administer first aid if needed, monitor for overdose, and provide referrals to drug treatment. 

The goal of the Rigaku HIHA Program is to provide analytical technology to OPCs in order to screen the drug supplies being brought into the facility for hazardous chemicals, such as fentanyl, as well as provide an identification for the substance.

The Rigaku portfolio of 1064 nm-Raman based analyzers provide non-destructive analysis of unknown substances through packaging in less than one minute with the press of a button.  The Rigaku ResQ CQL handheld analyzer contains a library with the latest illicit drugs, cutting agents, precursors, and hazardous chemicals - such as the various fentanyl compounds, as well as the ability to detect non-visible amounts with its use of QuickDetect Mode.

Designed for use in high stress environments, the Rigaku ResQ CQL uses a tactile platform, with smartphone-inspired software that can be operated via touchscreen or buttons.  With thousands of analyzers in use around the world by the military, border protection, law enforcement, as well as first responders – the Rigaku portfolio of handheld Raman analyzers have the ability to identify dirty or mixed substances, even through packaging.

“It’s time for a new, humanitarian, and progressive approach to saving lives from preventable drug overdoses ,” said Michael Brown, Global Business Development Manager for Narcotics Interdiction Programs at Rigaku Analytical Devices.  “Rigaku’s analyzers have the ability to provide frontline health responders with the ability to prevent a drug overdose before it happens.”

Rigaku’s HIHA Partnership Program provides a ResQ CQL with QuickDetect analyzer for an evaluation period, as well as training.

For more information on Rigaku’s HIHA Program, please visit www.rigakuanalytical.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rigaku Analytical Devices. (2022, May 10). Rigaku Announces Narcotics Interdiction Partnership Program to Help Reduce Deaths by Overdose. News-Medical. Retrieved on April 26, 2024 from https://www.news-medical.net/news/20220510/Rigaku-Announces-Narcotics-Interdiction-Partnership-Program-to-Help-Reduce-Deaths-by-Overdose.aspx.

  • MLA

    Rigaku Analytical Devices. "Rigaku Announces Narcotics Interdiction Partnership Program to Help Reduce Deaths by Overdose". News-Medical. 26 April 2024. <https://www.news-medical.net/news/20220510/Rigaku-Announces-Narcotics-Interdiction-Partnership-Program-to-Help-Reduce-Deaths-by-Overdose.aspx>.

  • Chicago

    Rigaku Analytical Devices. "Rigaku Announces Narcotics Interdiction Partnership Program to Help Reduce Deaths by Overdose". News-Medical. https://www.news-medical.net/news/20220510/Rigaku-Announces-Narcotics-Interdiction-Partnership-Program-to-Help-Reduce-Deaths-by-Overdose.aspx. (accessed April 26, 2024).

  • Harvard

    Rigaku Analytical Devices. 2022. Rigaku Announces Narcotics Interdiction Partnership Program to Help Reduce Deaths by Overdose. News-Medical, viewed 26 April 2024, https://www.news-medical.net/news/20220510/Rigaku-Announces-Narcotics-Interdiction-Partnership-Program-to-Help-Reduce-Deaths-by-Overdose.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.